Leland Stanford Junior University

University of California

Intima Bioscience, Inc.

University of Vienna

Universitat Wien

Charpentier, Emmanuelle

Lei S Qi

Luke A Gilbert

P C Dave P Dingal

Bo Huang

Adam P Arkin

Xiaoshu Xu

Baohui Chen

Jennifer A Doudna

Martin Jinek

Krzysztof Chylinski

Emmanuelle Charpentier

Wendell A Lim

James Harrison Doudna Cate

Bing C Wang

Rachel E Haurwitz

Modassir Choudhry

Jonathan S Weissman

Chang Liu

Martin Kampmann

Max Horlbeck

Xueqiu Lin

Provided herein are Cas proteins and guide RNA molecules engineered to exhibit increased activity in eukaryotic cells. The provided Cas proteins and RNA molecules are particularly useful for applications where modulation of eukaryotic nucleic acids with relatively small molecules is advantageous. Also provided are nucleic acids and vectors encoding the disclosed Cas proteins and guide RNA molecules, pharmaceutical compositions including the Cas proteins and guide RNA molecules, and methods for using the disclosed materials.

Synthetic miniature Crispr-Cas (CasMINI) system for eukaryotic genome engineering

Methods, compositions, and kits are provided herein for CRISPER/Cas-mediated nucleic acid detection or modification.

Optimized small guide RNAs and methods of use

The present disclosure provides systems, compositions and methods for regulating expression of a target polynucleotide in a cell. The systems, compositions and methods comprise a chimeric receptor polypeptide comprising a G-protein coupled receptor (GPCR) or a fragment thereof, a chimeric adaptor polypeptide, at least one actuator moiety and a cleavage moiety.

Chimeric proteins and methods of regulating gene expression

Fusion constructs encoding RNase-H-like domain containing compositions are disclosed. Disclosed are also compositions and methods utilizing RNase-H-like domain containing compositions for the treatment of cancer. Also disclosed are the methods of making and using the RNase-H-like domain containing compositions in treating various diseases, conditions, and cancer.

Nuclease systems for genetic engineering

Methods, compositions, and kits are provided for CRISPR/Cas mediated transcriptional modulation.

CRISPR/Cas transcriptional modulation

The present disclosure provides systems for immune cell regulation and methods of immunotherapy. Systems of the present disclosure for immune cell regulation comprise a chimeric receptor polypeptide, a chimeric adaptor polypeptide, a gene modulating polypeptide (GMP), and a cleavage moiety.

Chimeric proteins and methods of immunotherapy

The present disclosure provides nucleic acids encoding an RNA recognition sequence positioned proximal to an insertion site for the insertion of a sequence of interest; and host cells genetically modified with the nucleic acids. The present disclosure also provides methods of modifying the activity of a target RNA, and kits and compositions for carrying out the methods.

Methods and compositions for controlling gene expression by RNA processing

Provided herein are nucleic acid constructs that contain a synthetic control element that includes a cis-regulator of translation, and an adapter translation-coupled regulator of transcription. Further provided herein are nucleic acid constructs that contain nucleic acid sequences under the control of the synthetic control elements. Also provided are compositions and methods related to the nucleic acid constructs.

Synthetic transcriptional control elements and methods of generating and using such elements

Growing community of inventors

Stanford, CA, United States of America

Lei S Qi